Inhoudsopgave:
|
\u003cp\u003e\u003ci\u003eNanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Volume 171\u003c/i\u003e in the \u003ci\u003eInternational Review of Neurobiology\u003c/i\u003e series, highlights new advances in the field with this new volume presenting interesting chapters on Neurodegenerative diseases, Stress induced exacerbation of Alzheimer's disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-39988, Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress, Efficacy of invasive and non-invasive methods for the treatment of Parkinson´s disease: nanodelivery and enriched environment, and much more.\u003c/p\u003e \u003cp\u003eOther sections cover Sleep deprivation induced exacerbation of Parkinson's disease pathophysiology is attenuated by co-administration of nanowired cerebrolysin and serotonin-3 receptor antagonist ondansetron, Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury, Stress and brain diseases, Pathophysiology of sleep deprivation enhances amyloid beta peptide and p-tau in the CSF and brain, Neuroprotective effects of nanowired delivery of multimodal drug cerebrolysin and monoclonal 5-HT antibodies, Prior heat exposure exacerbates brain blast injury, Neuroprotection by nanodelivery of cerebrolysin with serotonin 6 receptor antagonist SB-399885, the Effects of curcumin nanodelivery on several brain pathologies, and more.\u003c/p\u003e\u003cul\u003e \u003cli\u003eProvides the authority and expertise of leading contributors from an international board of authors\u003c/li\u003e \u003cli\u003ePresents the latest release in \u003ci\u003eInternation Review on Neurobiology\u003c/i\u003e series\u003c/li\u003e \u003cli\u003eUpdated release includes the latest information on \u003ci\u003eNanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors\u003c/i\u003e\u003c/li\u003e\u003c/ul\u003e |
nl
en